Advertisement
U.S. markets open in 2 hours 48 minutes

Pfizer Inc. (PFE)

NYSE - NYSE Delayed Price. Currency in USD
27.72-0.22 (-0.79%)
At close: 04:00PM EDT
27.74 +0.02 (+0.07%)
Pre-Market: 06:39AM EDT

Pfizer Inc.

66 Hudson Boulevard East
New York, NY 10001-2192
United States
212 733 2323
https://www.pfizer.com

Sector(s)Healthcare
IndustryDrug Manufacturers - General
Full Time Employees88,000

Key Executives

NameTitlePayExercisedYear Born
Dr. Albert Bourla D.V.M., Ph.D.Chairman of the Board & CEO4.05MN/A1962
Mr. David M. DentonChief Financial Officer & Executive VP1.75MN/A1965
Dr. Mikael Dolsten M.D., Ph.D.Chief Scientific Officer and President of Research & Development2.41MN/A1958
Mr. Douglas M. LanklerExecutive VP & General Counsel1.76MN/A1966
Mr. Aamir MalikExecutive VP & Chief U.S. Commercial Officer1.89MN/A1976
Ms. Jennifer B. DamicoSenior VP, Controller & Principal Accounting OfficerN/AN/A1968
Ms. Lidia L. FonsecaExecutive VP and Chief Digital & Technology OfficerN/AN/A1969
Ms. Francesca M. DeMartinoChief Investor Relations OfficerN/AN/AN/A
Mr. Rady A. JohnsonExecutive VP and Chief Compliance, Quality & Risk OfficerN/AN/A1962
Mr. Andreas J. PanayiotouGlobal Chief Marketing OfficerN/AN/AN/A
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Corporate Governance

Pfizer Inc.’s ISS Governance QualityScore as of March 1, 2024 is 5. The pillar scores are Audit: 10; Board: 6; Shareholder Rights: 1; Compensation: 3.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.